Maravai LifeSciences Holdings, Inc. ( MRVI) - Stock Earnings
MRVI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -25.6 million USD | 41.6 million USD |
| 2025Q4 | -35.7 million USD | 49.9 million USD |
| 2026Q1 | -3.7 million USD | 65.8 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MRVI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -119.0 million USD | 288.9 million USD |
| 2024 | -144.8 million USD | 259.2 million USD |
| 2025 | -130.8 million USD | 185.7 million USD |
| 2026 Est. | — | — |
MRVI
Price: $4.98
52 week price:
Earnings Per Share: -0.71 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Market Capitalization: 1.4 billion